This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Paul Keckley Joins Navigant Healthcare As Managing Director

Today, Navigant (NYSE: NCI) announced that Paul Keckley has joined the firm as Managing Director and leader of the Navigant Center for Healthcare Research and Policy Analysis. With nearly 40 years of experience, Keckley brings extensive healthcare industry analysis and policy expertise to Navigant’s Healthcare leadership team.

“I am excited to welcome Paul to Navigant Healthcare. His knowledge of healthcare reform, his point of view on the future of the industry and his broad industry relationships create a differentiator for our practice,” stated David Zito, Managing Director and leader of Navigant Healthcare. “Paul’s unique experience will enhance our ability to provide actionable insights to our clients by combining industry perspectives with rigorous data analysis.”

Keckley will lead the Navigant Center for Healthcare Research and Policy Analysis. The Center will focus on trends and issues relevant to each of the industry’s major sectors. “Healthcare is capital intense, labor intense and highly regulated in the U.S. and in developed systems of the world,” Keckley said. “The Center’s role is to monitor signals from the market and identify innovative solutions that can help clients thrive in this fast-changing environment.”

Keckley previously served as the Executive Director for Deloitte’s Center for Health Solutions where he led a team of analysts and authored the recurring Monday Memo on Health Reform that was circulated among more than 20,000 U.S. health care organizations.

Keckley is a monthly columnist for Hospitals and Health Networks and writes the weekly Keckley Report which will continue as Navigant Healthcare’s Pulse Weekly. He has authored three books, 200 articles and is a frequent speaker and commentator in leading business media including the Economist, Wall Street Journal, Financial Times, Fox Business Network, Bloomberg Business, CNN, New York Times and Washington Post.

About Navigant Healthcare

Navigant (NYSE: NCI) provides a wide range of services, spanning from consulting and compliance to litigation and investigative support, to help highly-regulated industry organizations address their most critical business issues. Our Healthcare practice works collaboratively across a spectrum of clients in the payer, provider and life sciences space. Our professionals consist of industry thought leaders, healthcare executives, clinicians, physicians and seasoned consultants who assist health systems, physician organizations, payers and life sciences companies in designing, developing and implementing integrated, technology-enabled solutions that create high-performing healthcare organizations. Through a unique interdisciplinary approach leveraging the depth and breadth of our experience, Navigant Healthcare enables clients to build their capabilities and achieve sustainable peak performance around quality of care, cost, leadership, and culture in today’s changing healthcare environment.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 -1.15%
FB $117.58 0.73%
GOOG $693.01 0.29%
TSLA $240.76 -2.81%
YHOO $36.60 0.03%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs